Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Transduction01:16

Transduction

Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neutrophil degranulation and extracellular ROS production are inactivated by Yersinia pseudotuberculosis YopE through a SKAP2 independent pathway.

bioRxiv : the preprint server for biology·2026
Same author

Host Aging Induces a Senescent-Like Phenotype in Neutrophils and Altered Transcriptional Responses to Streptococcus pneumoniae.

Aging cell·2026
Same author

Host aging induces a senescent-like phenotype in neutrophils and altered transcriptional responses to <i>Streptococcus pneumoniae</i>.

bioRxiv : the preprint server for biology·2025
Same author

Large-scale combination screens reveal small-molecule sensitization of antibiotic-resistant gram-negative ESKAPE pathogens.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Non-canonical autophosphorylation of RIPK1 drives timely pyroptosis to control Yersinia infection.

Cell reports·2024
Same author

Blocking HXA<sub>3</sub>-mediated neutrophil elastase release during <i>S. pneumoniae</i> lung infection limits pulmonary epithelial barrier disruption and bacteremia.

mBio·2024

Related Experiment Video

Updated: Jul 6, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Evolutionary genetics: CCR5 mutation and plague protection.

Joan Mecsas1, Greg Franklin, William A Kuziel

  • 1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California 94305-5402, USA.

Nature
|February 13, 2004
PubMed
Summary

CCR5 deficiency may not protect against bubonic plague. Researchers infected normal and CCR5-deficient mice with Yersinia pestis, finding no difference in outcomes, suggesting the mutation offers no protection against this deadly bacterium.

More Related Videos

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
08:22

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

Published on: May 31, 2020

Efficient Retroviral Transduction and Competitive Homing for Investigating GPCR-Mediated T-Cell Localization in Diverse Tissue Microenvironments
09:12

Efficient Retroviral Transduction and Competitive Homing for Investigating GPCR-Mediated T-Cell Localization in Diverse Tissue Microenvironments

Published on: March 28, 2025

Related Experiment Videos

Last Updated: Jul 6, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
08:22

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

Published on: May 31, 2020

Efficient Retroviral Transduction and Competitive Homing for Investigating GPCR-Mediated T-Cell Localization in Diverse Tissue Microenvironments
09:12

Efficient Retroviral Transduction and Competitive Homing for Investigating GPCR-Mediated T-Cell Localization in Diverse Tissue Microenvironments

Published on: March 28, 2025

Area of Science:

  • Immunology
  • Genetics
  • Infectious Diseases
  • Evolutionary Medicine

Background:

  • A prevalent CCR5 (chemokine receptor type 5) mutation in Northern European populations has been hypothesized to confer protection against Yersinia pestis, the bacterium responsible for bubonic plague.
  • The historical impact of plague epidemics, particularly the one in the Middle Ages, highlights the significant public health implications of understanding host-pathogen interactions and potential genetic resistance factors.

Purpose of the Study:

  • To investigate the role of CCR5 deficiency in susceptibility and resistance to Yersinia pestis infection.
  • To experimentally test the proposed protective effect of the CCR5 mutation against bubonic plague.

Main Methods:

  • Infection of genetically modified mice lacking functional CCR5 receptors with Yersinia pestis.
  • Comparison of bacterial growth kinetics and survival rates between CCR5-deficient and normal (wild-type) mice.
  • Utilizing a murine model to simulate Yersinia pestis infection relevant to bubonic plague.

Main Results:

  • No significant difference was observed in bacterial growth of Yersinia pestis between normal mice and CCR5-deficient mice.
  • Survival times following Yersinia pestis infection were comparable in both experimental groups (normal vs. CCR5-deficient mice).
  • The CCR5 deficiency did not confer any discernible advantage or protection against the lethal effects of the bacterium in the studied model.

Conclusions:

  • The findings suggest that CCR5 deficiency is unlikely to be the protective factor against bubonic plague in humans.
  • The study indicates that the proposed link between CCR5 mutation and plague resistance may not be valid, unless Yersinia pestis pathogenesis differs significantly between mice and humans.
  • Further research is warranted to explore other potential genetic or environmental factors influencing human resistance to Yersinia pestis.